These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 30203342)

  • 1. Detection of Influenza in the Epidemic Season 2016/2017 Based on I-MOVE+ Project.
    Hallmann-Szelińska E; Cieślak K; Szymański K; Kowalczyk D; Korczyńska MR; Paradowska-Stankiewicz I; Brydak LB
    Adv Exp Med Biol; 2018; 1114():77-82. PubMed ID: 30203342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antigenic Drift of A/H3N2/Virus and Circulation of Influenza-Like Viruses During the 2014/2015 Influenza Season in Poland.
    Bednarska K; Hallmann-Szelińska E; Kondratiuk K; Brydak LB
    Adv Exp Med Biol; 2016; 905():33-8. PubMed ID: 26956457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influenza vaccine effectiveness estimates in Europe in a season with three influenza type/subtypes circulating: the I-MOVE multicentre case-control study, influenza season 2012/13.
    Kissling E; Valenciano M; Buchholz U; Larrauri A; Cohen JM; Nunes B; Rogalska J; Pitigoi D; Paradowska-Stankiewicz I; Reuss A; Jiménez-Jorge S; Daviaud I; Guiomar R; O'Donnell J; Necula G; Głuchowska M; Moren A
    Euro Surveill; 2014 Feb; 19(6):. PubMed ID: 24556348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaccine effectiveness in preventing laboratory-confirmed influenza in primary care patients in a season of co-circulation of influenza A(H1N1)pdm09, B and drifted A(H3N2), I-MOVE Multicentre Case-Control Study, Europe 2014/15.
    Valenciano M; Kissling E; Reuss A; Rizzo C; Gherasim A; Horváth JK; Domegan L; Pitigoi D; Machado A; Paradowska-Stankiewicz IA; Bella A; Larrauri A; Ferenczi A; ; Lazar M; Pechirra P; Korczyńska MR; Pozo F; Moren A;
    Euro Surveill; 2016; 21(7):pii=30139. PubMed ID: 26924024
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Repeated seasonal influenza vaccination among elderly in Europe: Effects on laboratory confirmed hospitalised influenza.
    Rondy M; Launay O; Castilla J; Costanzo S; Puig-Barberà J; Gefenaite G; Larrauri A; Rizzo C; Pitigoi D; Syrjänen RK; Machado A; Kurečić Filipović S; Krisztina Horváth J; Paradowska-Stankiewicz I; Marbus S; ; Moren A
    Vaccine; 2017 Aug; 35(34):4298-4306. PubMed ID: 28709555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Diagnostics of viral respiratory infections in hospitalized patients and ambulatory patients from SENTINEL program during 2004/05 season in Poland].
    Brydak LB; Lietzau G; Machała M
    Pol Arch Med Wewn; 2005 Oct; 114(4):958-67. PubMed ID: 16789521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibodies to Influenza Virus Hemagglutinin in the 2016/2017 Epidemic Season in Poland.
    Hallmann-Szelińska E; Cieślak K; Kowalczyk D; Szymański K; Brydak LB
    Adv Exp Med Biol; 2018; 1108():69-74. PubMed ID: 29931564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influenza vaccine effectiveness in Italy: Age, subtype-specific and vaccine type estimates 2014/15 season.
    Rizzo C; Bella A; Alfonsi V; Puzelli S; Palmieri AP; Chironna M; Pariani E; Piatti A; Tiberti D; Ghisetti V; Rangoni R; Colucci ME; Affanni P; Germinario C; Castrucci MR
    Vaccine; 2016 Jun; 34(27):3102-3108. PubMed ID: 27154392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Waning protection of influenza vaccine against mild laboratory confirmed influenza A(H3N2) and B in Spain, season 2014-15.
    Gherasim A; Pozo F; de Mateo S; Gamarra IA; García-Cenoz M; Vega T; Martínez E; Giménez J; Castrillejo D; Larrauri A;
    Vaccine; 2016 Apr; 34(20):2371-7. PubMed ID: 27020713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of previous and current vaccination against influenza A(H1N1)pdm09, A(H3N2), and B during the post-pandemic period 2010-2016 in Spain.
    Gherasim A; Martínez-Baz I; Castilla J; Pozo F; Larrauri A;
    PLoS One; 2017; 12(6):e0179160. PubMed ID: 28614376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surveillance for influenza--United States, 1997-98, 1998-99, and 1999-00 seasons.
    Brammer TL; Murray EL; Fukuda K; Hall HE; Klimov A; Cox NJ
    MMWR Surveill Summ; 2002 Oct; 51(7):1-10. PubMed ID: 12418623
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of seasonal influenza vaccination in community-dwelling elderly people: an individual participant data meta-analysis of test-negative design case-control studies.
    Darvishian M; van den Heuvel ER; Bissielo A; Castilla J; Cohen C; Englund H; Gefenaite G; Huang WT; la Bastide-van Gemert S; Martinez-Baz I; McAnerney JM; Ntshoe GM; Suzuki M; Turner N; Hak E
    Lancet Respir Med; 2017 Mar; 5(3):200-211. PubMed ID: 28189522
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influenza vaccine effectiveness in preventing hospitalizations with laboratory-confirmed influenza in Greece during the 2014-2015 season: A test-negative study.
    Lytras T; Kossyvakis A; Melidou A; Andreopoulou A; Exindari M; Gioula G; Kalliaropoulos A; Tryfinopoulou K; Pogka V; Spala G; Malisiovas N; Mentis A
    J Med Virol; 2016 Nov; 88(11):1896-904. PubMed ID: 27088266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaccine Effectiveness against Influenza in 2015/16 in Hospital and Ambulatory Medical Care Facilities: Polish Results of the European I-MOVE+ Multicenter Study.
    Paradowska-Stankiewicz I; Korczyńska MR; Cieślak K; Kowalczyk D; Szymański K; Brydak LB
    Adv Exp Med Biol; 2018; 1023():93-100. PubMed ID: 28730379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low influenza vaccine effectiveness and the effect of previous vaccination in preventing admission with A(H1N1)pdm09 or B/Victoria-Lineage in patients 60 years old or older during the 2015/2016 influenza season.
    Puig-Barberà J; Guglieri-López B; Tortajada-Girbés M; López-Labrador FX; Carballido-Fernández M; Mollar-Maseres J; Schwarz-Chavarri G; Baselga-Moreno V; Mira-Iglesias A; Díez-Domingo J;
    Vaccine; 2017 Dec; 35(52):7331-7338. PubMed ID: 29128380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Infections with Influenza A/H3N2/ Subtype in Poland in the 2016/2017 Epidemic Season.
    Szymański K; Kowalczyk D; Cieślak K; Hallmann-Szelińska E; Brydak LB
    Adv Exp Med Biol; 2018; 1108():93-98. PubMed ID: 30051316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influenza in Poland in 2011-2012 and in 2011/2012 and 2012/2013 epidemic seasons.
    Czarkowski MP; Hallmann-Szelińska E; Staszewska E; Bednarska K; Kondratiuk K; Brydak LB
    Przegl Epidemiol; 2014; 68(3):455-63, 559-65. PubMed ID: 25391010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Virological and Epidemiological Situation in the Influenza Epidemic Seasons 2016/2017 and 2017/2018 in Poland.
    Hallmann-Szelińska E; Łuniewska K; Szymański K; Kowalczyk D; Sałamatin R; Masny A; Brydak LB
    Adv Exp Med Biol; 2020; 1251():107-113. PubMed ID: 31832902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of previous episodes of influenza and vaccination in preventing laboratory-confirmed influenza in Navarre, Spain, 2013/14 season.
    Castilla J; Navascués A; Fernández-Alonso M; Reina G; Albéniz E; Pozo F; Álvarez N; Martínez-Baz I; Guevara M; García-Cenoz M; Irisarri F; Casado I; Ezpeleta C;
    Euro Surveill; 2016 Jun; 20(22):. PubMed ID: 27277013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Occurrence of Influenza Hemagglutinin Antibodies in the Polish Population during the Epidemic Season 2017/18.
    Hallmann-Szelińska E; Szymański K; Łuniewska K; Masny A; Kowalczyk D; Sałamatin R; Brydak LB
    Adv Exp Med Biol; 2019; 1222():69-73. PubMed ID: 31637606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.